Vaxneuvance

pneumococcal polysaccharide conjugate vaccine (adsorbed) · Merck Sharp & Dohme B.V.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Vaxneuvance, covering 2026-01-06 to 2026-07-16. Get the full timeline:

Most recent: EMA Authorised: Vaxneuvance (pneumococcal polysaccharide conjugate vaccine (adsorbed)) — Merck Sharp & Dohme B.V.